Warning: Trying to access array offset on null in /WWW/OHD/www.otsuka.com/vendor/linear/blocs/lib/Core.php on line 371

Warning: foreach() argument must be of type array|object, null given in /WWW/OHD/www.otsuka.com/vendor/linear/blocs/lib/Core.php on line 371
Otsuka Group News | Otsuka Holdings Co., Ltd.

Otsuka Group News

Keyword search

Add search criteria

Search by company

Otsuka Holdings
Otsuka Pharmaceutical
Otsuka Pharmaceutical Factory
Taiho Pharmaceutical
Otsuka Warehouse
Otsuka Chemical
Otsuka Foods
Otsuka Medical Devices
Other

Search by category^*

Pharmaceuticals Business
Nutraceuticals Business
Consumer Products Business
Others
Products
R&D
Personnel
Corporate

* Business categories are based on the business segments described in the financial announcements.

Search by release date

-

First 30 results

June 29, 2026
Otsuka Pharmaceutical

Joint Research with Tohoku University Establishment of a Collaborative Research Program on Water Turnover and Total Conditioning
June 25, 2026
Otsuka Pharmaceutical

Otsuka Announces Positive Phase 3b Results for Centanafadine in Adults with ADHD and Comorbid Anxiety
June 25, 2026
Taiho Pharmaceutical

Taiho Pharmaceutical Earns First Silver Medal in EcoVadis Sustainability Rating
June 24, 2026
Otsuka Pharmaceutical

Otsuka America Establishes the POCARI SWEAT SCIENCE ADVISORY BOARD Announces New Heat Illness Prevention Guidance to Address Heat Challenges in the United States
June 15, 2026
Otsuka Pharmaceutical

Otsuka Pharmaceutical Completes Acquisition of Transcend Therapeutics
June 11, 2026
Otsuka Foods

Otsuka Foods’ Biwako Research Institute Develops “Oishisa LENS,” an AI System That Predicts Flavor Profiles and Recipes to Secure Expertise Transfer and Enhance Product Design 58 Years After the Brand’s Launch, Preserving Bon Curry’s Signature Taste for the Next Generation
June 5, 2026
Otsuka Pharmaceutical

Otsuka Establishes “Heatstroke Countermeasure Industry-Government-Academia Consortium” with the National Institute for Environmental Studies and Other Partners
June 5, 2026
Otsuka Pharmaceutical

Otsuka Presents Positive Interim Phase 3 VISIONARY eGFR Data Showing VOYXACT (sibeprenlimab-szsi) Preserved Kidney Function Over 12 Months in IgA Nephropathy (IgAN)
May 29, 2026
Otsuka Pharmaceutical

Otsuka Presents New Phase 3 Post Hoc Analyses of Centanafadine Highlighting Improvement in Executive Function and Emotional Dysregulation in Adults with ADHD at the 2026 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting
May 18, 2026
Otsuka Pharmaceutical

Otsuka Launches New Program FACEDUO “Heat Illness Prevention VR” Enabling Early Awareness and Action Through Simulated Experiences to Help Prevent the Onset and Severity of Heat Illness in Older Adults
May 14, 2026
Taiho Pharmaceutical

U.S. FDA Approves INQOVI® in Combination with Venetoclax, the First All-Oral Combination Treatment for Patients with Acute Myeloid Leukemia Who Are Ineligible for Intensive Induction Chemotherapy
April 30, 2026
Otsuka Pharmaceutical

Otsuka Launches “Educational Materials and Resources by Otsuka” for Educators to Support Health Education in Schools Providing Free Digital Health Education Materials on Heat Illness Prevention and Nutrition Education
April 28, 2026
Taiho Pharmaceutical

U.S. Food and Drug Administration Accepts New Drug Application for Zipalertinib for the Treatment of Locally Advanced or Metastatic Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
April 28, 2026
Taiho Pharmaceutical

Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development
April 23, 2026
Otsuka Medical Devices

Recor Medical's Paradise Ultrasound Renal Denervation System Honored with TAG Award for Cardiovascular Therapeutic Innovation (Link to Recor website)
April 21, 2026
Otsuka Pharmaceutical

Efficacy of Lactic Acid Bacterium ONRICb0240 Against Gingivitis Confirmed A collaborative study with the Institute of Science Tokyo brings new hope for oral care
April 21, 2026
Taiho Pharmaceutical

Update on the Phase 3 STAR-121 Study of Anti-TIGIT Antibody Domvanalimab and Anti-PD-1 Antibody Zimberelimab in Non-Small Cell Lung Cancer
April 20, 2026
Otsuka Foods

Otsuka Foods to Revise Prices of Some Products New Prices to Take Effect with Deliveries as of June 1, 2026
April 17, 2026
Otsuka Pharmaceutical

Otsuka Pharmaceutical Receives Judges’ Special Award at MAFF’s 10th Shokuiku Activity Awards “MoguMogu Town” App Recognized for Promoting Food and Nutrition Education
April 1, 2026
Otsuka Pharmaceutical

Otsuka Pharmaceutical Recognized as a “Food and Nutrition Education Practice Excellent Corporation 2026” by the MAFF Leveraging Proprietary Expertise and Services to Promote Health through Nutrition
April 1, 2026
Otsuka Holdings

Otsuka Holdings Certified by the Ministry of Agriculture, Forestry and Fisheries as a “Food and Nutrition Education Practice Excellent Corporation 2026” Promoting Health by Leveraging the Group’s Expertise, Products, and Services
March 27, 2026
Otsuka Pharmaceutical

Otsuka Pharmaceutical to Acquire Transcend Therapeutics - Expands Otsuka portfolio in psychiatric and neurological fields and aims to accelerate development of Transcend’s portfolio, including the TSND-201 program for post-traumatic stress disorder (PTSD) -
March 27, 2026
Otsuka Holdings

Otsuka Holdings appoints Board Members and Auditors and Supervisory Board Members
March 27, 2026
Otsuka Pharmaceutical

Otsuka Submits Application in Japan for Iclusig® for First-Line Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
March 25, 2026
Otsuka Holdings

OTSUKA Health Comic Library II Publication of “Water Is Amazing!: The Health of People and the Planet and the Power of Water” Donated to All Elementary Schools Throughout Japan
March 13, 2026
Otsuka Pharmaceutical

Otsuka Unveils New Repinatrabit Open-Label Extension Data in Phenylketonuria (PKU) Signaling Efficacy in Adolescents at the 2026 American College of Medical Genetics and Genomics (ACMG) Meeting
March 11, 2026
Otsuka Pharmaceutical

Launch of Joint Sales of the QuickNavi™-Campylobacter Antigen Diagnostic Kit in Japan
March 9, 2026
Otsuka Pharmaceutical

New and Improved Calorie Mate JELLY Enhanced Taste and Balanced Nutrition, Now Even More Accessible
March 4, 2026
Otsuka Pharmaceutical

Otsuka Pharmaceutical Named Tokyo Sports Promotion Model Company (Sports Practice Category) Employee and Communities Health Initiatives Recognized
March 3, 2026
Otsuka Pharmaceutical

New Release: SOYJOY Azuki & Hojicha A Deep Japanese Flavor with Gentle Sweetness and a Roasted Aroma